Statistics for CureVac NV (id:6438 CVAC)

Valuation metrics

Market cap

569.82M

Enterprise value

427.95M

Trailing P/E (ttm)

-2.11

Forward P/E

-5.77

PEG ratio

-5.77

Price/Sales (ttm)

8.65

Price/Book (mrq)

1.51

Enterprise Value/Revenue

6.17

Enterprise Value/EBITDA

-1.50

Overview

Shares outstanding

224.34M

Float

123.54M

Shares short

4.56M

% Held by insiders

0.45%

% Held by institutions

0.19%

Average volume (10 days)

686.77K

Average volume (90 days)

Price summary

52-Week low

2.22

52-Week high

6.30

52-Week change

-118.88%

Beta

2.61

50-Day moving average

2.93

200-Day moving average

3.21

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-131.34%

Operating margin

-493.58%

Operational effectiveness

Return on assets

-24.52%

Return on equity

-54.30%

Income statement

Revenue (ttm)

0.29

Revenue per share (ttm)

0.29

Quarterly revenue growth (yoy)

Gross profit (ttm)

-70,608,000.00

EBITDA

-284,764,762.00

Net income to common (ttm)

-293,284,257.00

Diluted EPS (ttm)

-1.32

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

213.32M

Total cash per share (mrq)

0.90

Total debt (mrq)

41.12M

Total Debt/Equity (mrq)

10.37

Current ratio (mrq)

228.70%

Book value per share (mrq)

1.68

Cash flow

Cash flow statement

-305,315,604.00

Levered free cash flow (LFCF)

-233,947,990.00